Author:
Choi Dong Hyun,Bae Hak Yeon,Choi Jun Shik
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference22 articles.
1. Alhenz-Gelas, F., Plouin, P. F., Ducrocq, M. B., Corvol, P. E., and Menard, J., Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker acebutolol and diuretics in essential hypertension.Am. J. Med., 64, 1005–1012 (1978).
2. Baker, P. G. and Goulton, J. A., Multicentre study of a once daily dosage of acebutolol in the treatment of hypertension in general practice.J. Int. Med. Res., 7, 201–214 (1979).
3. Basil, J. and Jordan, R., Pharmacological properties of diacetolol, a major metabolite of acebutolol.Eur. J. Pharmacol., 80, 47–56 (1982).
4. Buskin, J. N., Upton, R. A., Jones, R., and Williams, R. L., High performance liquid chromatography assay of acebutolol and its metabolites in plasma and urine.J. Chromatogr., 230, 438–442 (1982).
5. Choi, Y. J., Lee, H. J., Kwon, J. W., Kim, W. B., Yang, J., and Lee, M. G., Pharmacokinetic change of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus.Res. Commun. Mol. Pathol. Pharmacol., 94, 181–192 (1996).